ABSTRACT Current standards for detection of myocarditis in a clinical setting rely on endomyocardial biopsy for accurate diagnosis. With this technique a subset of patients with dilated cardiomyopathy show unsuspected myocarditis histologically.
DILATED CARDIOMYOPATHY is a clinical syndrome that frequently culminates in progressive congestive heart failure and premature death. The etiology of dilated cardiomyopathy is obscure by definition; consequently, current therapy is neither specific nor life prolonging. ' The recent development of safe techniques of endomyocardial biopsy has led to the realization that patients with dilated cardiomyopathy may have unsuspected myocarditis and that the inflammatory infiltrates are potentially reversible.2 Immunosuppressive therapy may ultimately lead to improvement of clinical symptoms and prognosis if the myocardium has not been irreversibly damaged. Although safe when performed by experienced hands, endomyocardial biopsy is not the ideal diagnostic tool because of its morbidity, cost, and potential for sampling error, which may cause low sensitivity when the inflammatory infiltrate is patchy or focal -a common finding in myocarditis.
The ideal noninvasive screening test should have high sensitivity, low morbidity, and low cost. Inflammation-sensitive radioisotopic imaging has great potential for this role. Gallium-67 (67Ga) is a radioisotope that is routinely used to identify chronic inflammatory reactions with a reported sensitivity of 90%. and 67Ga scans because the initial biopsy showed active myocarditis. Results of the initial biopsies of these patients showed extensive inflammatory infiltration and all three were placed on prednisone (1 mg/kg) and azathioprine (2.5 mg/kg). Two of the patients showed conversion of the 67Ga scans to negative within 3 months, when both biopsies showed resolution of the infiltrate. Serial studies in the third patient during im- The availability of safe endomyocardial biopsy allows serial histologic evaluation of the myocardium.7
By this technique, myocarditis has been identified in 8% to 25% of patients with dilated cardiomyopathy.8-Critics of myocardial biopsy cite the morbidity, cost, and sampling error as disadvantages. Although quantification of sampling error cannot be accurately calculated, focal or patchy inflammation may be missed by biopsy, and this technique may lack the sensitivity of an ideal screening test.
The specificity of myocardial biopsy is contingent on the definition of myocarditis. The number of lymphocytes in the interstitium necessary to justify histologic diagnosis of myocarditis and the significance of myocyte necrosis remains controversial.9' 1 Our working definition of myocarditis is conservative, requiring both lymphocyte quantitation and myocyte necrosis. Although the lack of defined specificity and sensitivity of endomyocardial biopsy diminishes its utility, this remains the only reference point for comparison of techniques.
67Ga is useful clinically in the detection of noncardiac chronic inflammatory states.12-14 It has also been shown to be useful in the detection of inflammation in bacterial endocarditis,'5 myocardial abscess,'6 myocardial sarcoidosis,'7 and pericardial disease.4 We initially described gallium uptake in three patients with dilated cardiomyopathy, two of whom showed response to immunosuppressive therapy.5 When our patient population was expanded it became obvious that 67Ga imaging may not be specific for active myocarditis.6 Yet, follow-up 67Ga uptake correlated closely with clinical improvement. This sequential correlation prompted us to compare results of 67Ga imaging with those of endomyocardial biopsy for detection of myocarditis.
In this study, consecutive patients without clinical evidence of myocarditis underwent endomyocardial biopsy within 72 hr of 67Ga imaging as part of the initial evaluation of dilated cardiomyopathy. Eight percent of these biopsy specimens showed myocarditis. When clinical and hemodynamic parameters were analyzed, no discriminating feature could identify those patients with myocarditis on biopsy. Eighty-seven percent (5/6) of positive biopsy results had associated dense 67Ga myocardial uptake. The sole patient without myocardial uptake had an abnormal 67Ga scan of the chest because of posterior mediastinal lymph node uptake that possibly obscured myocardial uptake. In patients with positive 67Ga scans, there was a 36% incidence of myocarditis on biopsy. The patients with dilated cardiomyopathy for identification of a subpopulation with a high yield of myocarditis on endomyocardial biopsy. Fourteen percent of patients without evidence of active myocarditis on biopsy had 67Ga uptake. The uptake of 67Ga in patients with positive biopsy results was obvious by our imaging techniques in all scans and subject to little variability in interpretation. However, in patients without evidence of myocarditis in biopsy specimens the uptake was not as dense (equivocal grade). When patients with positive 67Ga scans and negative biopsy results were compared with those with negative 67Ga scans and negative biopsy results, we noted elevated ESR and higher ejection fractions in the former. When viewed in the context of possible biopsy sampling error, perhaps some of these false-positive 67Ga scans may in fact represent false-negative biopsy findings. Serial endomyocardial biopsies and 67Ga scans were performed in three patients with initially positive biopsy results and 67Ga scans. The follow-up 67Ga scan correlated precisely to the follow-up biopsy in each.
Similar results have been reported recently by others. Shanes et al.,18 in a small series, noted that a positive 67Ga scan usually correlated with the presence of inflammatory cells on endomyocardial biopsy. Strain et al.,"9 when comparing 67Ga scans with myocardial biopsy results in nine patients with biopsyproven chronic myocarditis, found gallium to be highly specific but insensitive, with a predictive value of 58%. The discrepancy in utility of 67Ga scanning between their analysis and ours may stem from the pathologic interpretation of biopsy results.
Although 67Ga imaging is useful in the screening for inflammation in patients with dilated cardiomyopathy, there are several technique-dependent sources of error that could decrease the sensitivity. Scans should be performed 72 hr after injection of the isotope. If imaging is performed at 24 hr, 67Ga may not clear the blood pool and a false-positive 67Ga scan will result. If scanning is performed at 48 hr, the heart may be imaged but high background counts may decrease the sensitivity. Positioning of the gamma camera is very important. Scanning should be performed in the anterior as well as oblique projections so that localized uptake may be confirmed as myocardial in origin. In lactating or premenstrual women, breast uptake usually obscures the heart in the anterior projection, and if dense may totally obscure the heart. Most of the liver should be excluded from the field of view. The tendency to include more of the liver to cut down on the scanning time necessary to achieve the optimal 625,000 counts should be avoided because it reduces counts detected 61 from the myocardium. Only latest-generation gamma cameras with good low-energy resolution should be used, and collimation should cover three 67Ga energy peaks. Computer background enhancement is important for improving the sensitivity of the examination, but enhancement should never be greater than 20% of the maximal pixel.
In summary, 67Ga imaging may be used as a screening tool to identify a population of patients with a high yield of myocarditis on endomyocardial biopsy. Once the correlation between 67Ga scanning and biopsy results is established in an individual patient, 67Ga imaging may be a useful technique for the serial evaluation of the patient, obviating the necessity for frequent endomyocardial biopsies.
